Fundz

Boston Scientific Announces Acquisition Of Obsidio, Inc.

PUBLIC · BSXAug 15, 2022

Acquiring Company

Boston Scientific

Acquired Company

Obsidio

MarlboroughManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEMTM) technology used for embolization of blood vessels in the peripheral vasculature.

Quick answer

Boston Scientific is acquiring Obsidio, announced August 15, 2022. Boston Scientific is based in Marlborough, Massachusetts, United States.

How much did Boston Scientific pay for Obsidio?
The deal value was not disclosed.
What does Boston Scientific do?
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.
Where are Boston Scientific and Obsidio based?
Boston Scientific is based in Marlborough, Massachusetts, United States.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Medical Device

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Boston Scientific, and when

When Boston Scientific changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Boston Scientific raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Boston Scientific, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Boston Scientific. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Boston Scientific

Location

300 Boston Scientific Way

Marlborough, Massachusetts, United States

About

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Boston Scientific makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Boston Scientific's next move

Learn about Strategic plan

Frequently asked

Who acquired Obsidio?

Obsidio was acquired by Boston Scientific, based in Marlborough. The deal was reported on August 15, 2022. Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific is publicly traded (BSX) and operates in Manufacturing.

When did Boston Scientific acquire Obsidio?

Boston Scientific's acquisition of Obsidio was reported on August 15, 2022. Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEMTM) technology used for embolization of blood vessels in the peripheral vasculature. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Obsidio do?

Just another WordPress site It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.